Seneca Foods Corp is a us-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen and bottled produce and snack chips. It generates maximum revenue from Canned vegetables followed by Frozen vegetables. Seneca Foods Corp is a us-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen and bottled produce and snack chips. It generates maximum revenue from Canned vegetables followed by Frozen vegetables.
Novel small molecule FF-10158 targets integrin alphavbeta3 (avβ3) and alphavbeta5 (avβ5) receptors Expands theragnostic pipeline Potential broad application in the detection and treatment of...
SAINT-GENIS-POUILLY, France, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a Novartis company and leader in nuclear medicine...
SAINT-GENIS-POUILLY, France, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), a Novartis company and a leader in nuclear...
First-in-class Therapy Demonstrated 79% Improvement in Progression Free Survival in NETTER-1 Phase 3 Study in Midgut NET Patients Lutathera (lutetium Lu 177 dotatate...
SAINT-GENIS-POUILLY, France, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), a leader in nuclear medicine theragnostics...
SAINT-GENIS-POUILLY, France, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today...
SAINT-GENIS-POUILLY, France, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today...
$3.9 Billion All Cash Proposed Tender Offer by Novartis European Approval of Lutetium Lu 177 Dotatate* (Lutathera®) for GEP-NETs Recent Highlights: Sales for the third quarter of 2017...
SAINT-GENIS-POUILLY, France, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.88 | -4.76900149031 | 60.39 | 60.8216 | 57.36 | 615 | 59.5616043 | CS |
4 | -3.2 | -5.27096030308 | 60.71 | 64.5 | 57.36 | 873 | 59.90389967 | CS |
12 | -4.74 | -7.61445783133 | 62.25 | 64.5 | 55.77 | 661 | 60.25074164 | CS |
26 | 6.44 | 12.6101429411 | 51.07 | 64.5 | 45 | 463 | 58.00501324 | CS |
52 | 17.66 | 44.3161856964 | 39.85 | 64.5 | 39.85 | 486 | 55.30958991 | CS |
156 | 9.02 | 18.6017735616 | 48.49 | 71.25 | 31.51 | 410 | 52.07930951 | CS |
260 | 26.26 | 84.032 | 31.25 | 71.25 | 24.71 | 387 | 49.07905941 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約